(Q33573968)

28 July 2017

1 reference

title

Formulary management of ACE inhibitors (English)

1 reference

28 July 2017

Gerbrandt KR

1

1 reference

28 July 2017

Yedinak KC

series ordinal

2

1 reference

28 July 2017

publication date

1 December 1996

1 reference

28 July 2017

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

594-613

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-199610060-00006

28 July 2017

exact match

0 references

cites work

Cost of switching hypertensive patients from enalapril maleate to lisinopril.

1 reference

12 December 2020

Differences in structure of angiotensin-converting enzyme inhibitors might predict differences in action

1 reference

12 December 2020

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

1 reference

12 December 2020

Double blind controlled study of low dose intravenous perindoprilat or enalaprilat infusion in elderly patients with heart failure

1 reference

12 December 2020

Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs

1 reference

12 December 2020

Left ventricular remodelling, neurohormonal activation and early treatment with enalapril (CONSENSUS II) following myocardial infarction

1 reference

12 December 2020

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

1 reference

12 December 2020

Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients

1 reference

12 December 2020

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

12 December 2020

Comparison of captopril and enalapril in patients with severe chronic heart failure

1 reference

12 December 2020

Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function

1 reference

12 December 2020

Pharmacokinetic and pharmacologic properties of delapril, a lipophilic nonsulfhydryl angiotensin-converting enzyme inhibitor

1 reference

12 December 2020

Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor

1 reference

12 December 2020

Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease

1 reference

12 December 2020

GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico

1 reference

12 December 2020

Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors.

1 reference

12 December 2020

Drug-patient interactions and their relevance in the treatment of heart failure

1 reference

12 December 2020

Decision analysis applied to the selection of angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Indications for immediate angiotensin-converting enzyme inhibition in patients with acute myocardial infarction

1 reference

12 December 2020

General well-being during treatment with different ACE-inhibitors: two double-blind placebo-controlled cross-over studies in healthy volunteers

1 reference

12 December 2020

ACE inhibitors in non-diabetic renal disease

1 reference

12 December 2020

Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol.

1 reference

12 December 2020

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

12 December 2020

Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group

1 reference

12 December 2020

Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure

1 reference

12 December 2020

ACE for whom? Implications for clinical practice of post-infarct trials

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Therapeutic progress. III: Diabetic nephropathy

1 reference

12 December 2020

Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension

1 reference

12 December 2020

1 reference

12 December 2020

Influence of food on acute and chronic effects of captopril in essential hypertensive patients.

1 reference

12 December 2020

Angiotensin-Converting Enzyme Inhibitors and Insulin Sensitivity: Metabolic Effects in Hypertension, Diabetes, and Heart Failure

1 reference

12 December 2020

Socioeconomic aspects of ACE inhibition in the secondary prevention in cardiovascular diseases.

1 reference

12 December 2020

ACE inhibitors after myocardial infarction: patient selection or treatment for all?

1 reference

12 December 2020

Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical structure and biologic activity.

1 reference

12 December 2020

Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

12 December 2020

Angiotensin-Converting Enzyme Inhibitors Post-Myocardial Infarction

1 reference

12 December 2020

Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group.

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors after myocardial infarction: indications and timing.

1 reference

12 December 2020

Use of 'Xapril' in patients with chronic heart failure. A paradigm or epitaph for our times?

1 reference

12 December 2020

Comparative properties of angiotensin-converting enzyme inhibitors: Relations with inhibition of tissue angiotensin-converting enzyme and potential clinical implications

1 reference

12 December 2020

ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collabor

1 reference

12 December 2020

Ramipril. An updated review of its therapeutic use in essential hypertension and heart failure

1 reference

12 December 2020

Meta-analysis of morbidity and mortality in five exercise capacity trials evaluating ramipril in chronic congestive cardiac failure

1 reference

12 December 2020

The measurement of quality of life in evaluating ACE inhibitors

1 reference

12 December 2020

Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders

1 reference

12 December 2020

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

12 December 2020

Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors

1 reference

12 December 2020

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

1 reference

12 December 2020

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

1 reference

12 December 2020

Pharmacokinetics of fosinopril in patients with various degrees of renal function

1 reference

12 December 2020

Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition

1 reference

12 December 2020

Selected aspects of ACE inhibitor therapy for patients with renal disease: impact on proteinuria, lipids and potassium

1 reference

12 December 2020

Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy

1 reference

12 December 2020

Newer ACE inhibitors. A look at the future

1 reference

12 December 2020

Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1)

1 reference

12 December 2020

Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study

1 reference

12 December 2020

Perindopril. A review of its pharmacokinetics and clinical pharmacology

1 reference

12 December 2020

The safety and tolerability of quinapril

1 reference

12 December 2020

Early and late angiotensin-converting enzyme inhibition in acute myocardial infarction

1 reference

12 December 2020

Development and prevention of congestive heart failure following myocardial infarction.

1 reference

12 December 2020

Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure

1 reference

12 December 2020

The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)

1 reference

12 December 2020

Enalapril to Lisinopril: Economic Impact of a Voluntary Angiotensin-Converting Enzyme-Inhibitor Substitution Program in a Staff-Model Health Maintenance Organization

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors in diabetic nephropathy

1 reference

12 December 2020

Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy

1 reference

12 December 2020

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

12 December 2020

Nephroprotective effect of ACE inhibitors

1 reference

12 December 2020

Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

The new trials: AIRE, ISIS-4, and GISSI-3. Is the dossier on ACE inhibitors and myocardial infarction now complete?

1 reference

12 December 2020

Pharmacokinetics of captopril and its effects on blood pressure during acute and chronic administration and in relation to food intake.

1 reference

12 December 2020

Comparative pharmacokinetics of captopril, enalapril, and quinapril

1 reference

12 December 2020

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

1 reference

12 December 2020

Comparison of the Steady-State Pharmacokinetics of Fosinopril, Lisinopril and Enalapril in Patients with Chronic Renal Insufficiency

1 reference

12 December 2020

Inhibition of angiotensin-converting enzyme (ACE) in plasma and tissue.

1 reference

12 December 2020

Congestive heart failure in elderly patients: controlled study of delapril versus captopril.

1 reference

12 December 2020

Angiotensin converting enzyme inhibitors and quality of life

1 reference

12 December 2020

Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update

1 reference

12 December 2020

ACE inhibitors after myocardial infarction: selection and treatment for all

1 reference

12 December 2020

Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy

1 reference

12 December 2020

Adverse effects of angiotensin-converting enzyme inhibitors in antihypertensive therapy with focus on quinapril

1 reference

12 December 2020

Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension

1 reference

12 December 2020

10.2165/00019053-199610060-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1026960312

0 references

1 reference